%0 Journal Article
%A Korshunov, Andrey
%A Okonechnikov, Konstantin
%A Stichel, Damian
%A Ryzhova, Marina
%A Schrimpf, Daniel
%A Sahm, Felix
%A Sievers, Philipp
%A Absalyamova, Oksana
%A Zheludkova, Olga
%A Golanov, Andrey
%A Jones, David T W
%A Pfister, Stefan M
%A von Deimling, Andreas
%A Kool, Marcel
%T Integrated molecular analysis of adult Sonic Hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator.
%J Neuro-Oncology
%V 23
%N 9
%@ 1523-5866
%C Oxford
%I Oxford Univ. Press
%M DKFZ-2021-00383
%P 1576-1585
%D 2021
%Z #EA:B300#B062#LA:B062# / 2021 Sep 1;23(9):1576-1585
%X Up to now, adult medulloblastoma (MB) patients are treated according to the protocols elaborated for pediatric MB although these tumors are different in terms of clinical outcomes and biology. Approximately 70
%K Adult (Other)
%K Medulloblastoma (Other)
%K SHH (Other)
%K VEGFA (Other)
%K prognosis (Other)
%K transcriptome (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:33589929
%R 10.1093/neuonc/noab031
%U https://inrepo02.dkfz.de/record/167482